C57BL/6J STZ-Induced Diabetes Data

Phenotype of C57BL/6J mice treated with STZ

6 week old C57BL/6J males (000664) males received daily intraperitoneal injections of 50 mg/kg streptozotocin (STZ) or buffer control for five days.

Figure 1.  Non-fasted blood glucose was measured weekly from the submandibular route using a OneTouch UltraMini glucometer. The STZ treatment group contained 38 mice with blood glucose exceeding 250 mg/dL when measured two weeks after the first injection. The control group contained 19 mice.